Back to hamad.qa
عربي
Staff login

Publications

2024

  1. Abdel Hadi, H., Dargham, S. R., Eltayeb, F., Ali, M. O. K., Suliman, J., Ahmed, S. A. M., Omrani, A. S., Ibrahim, E. B., Chen, Y., Tsui, C. K. M., Skariah, S., & Sultan, A. (2024). Epidemiology, Clinical, and Microbiological Characteristics of Multidrug-Resistant Gram-Negative Bacteremia in Qatar. Antibiotics (Basel, Switzerland), 13(4), 320. https://doi.org/10.3390/antibiotics13040320

  2. Al Mana, H., Abdel Hadi, H., Wilson, G., Almaslamani, M. A., Abu Jarir, S. H., Ibrahim, E., & Eltai, N. O. (2024). Antimicrobial Resistance in Qatar: Prevalence and Trends before and Amidst the COVID-19 Pandemic. Antibiotics (Basel, Switzerland), 13(3), 203. https://doi.org/10.3390/antibiotics13030203

  3. Ali, G. A., Pérez-López, A., Tsui, C., Shunnar, K., Sharma, A., Ibrahim, E. B., Tang, P., Alsoub, H., & Goravey, W. (2024). Streptococcus gordonii-associated infective endocarditis: Case series, literature review, and genetic study. Clinical case reports, 12(4), e8684. https://doi.org/10.1002/ccr3.8684

  4. Alkhayyat, R., Abbas, A., Quinn, C. M., & Rakha, E. A. (2024). Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls. Histopathology, 84(5), 723–741. https://doi.org/10.1111/his.15101

  5. Azam, A. S., Tsang, Y. W., Thirlwall, J., Kimani, P. K., Sah, S., Gopalakrishnan, K., Boyd, C., Loughrey, M. B., Kelly, P. J., Boyle, D. P., Salto-Tellez, M., Clark, D., Ellis, I. O., Ilyas, M., Rakha, E., Bickers, A., Roberts, I. S. D., Soares, M. F., Neil, D. A. H., Takyi, A., … Snead, D. R. J. (2024). Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite study. Histopathology, 84(5), 847–862. https://doi.org/10.1111/his.15129

  6. Chia, N., Gudi, M. A., Rakha, E., & Tan, P. H. (2024). HER2-low breast cancers: challenges in the interpretation of immunohistochemistry. Singapore medical journal, 10.4103/singaporemedj.SMJ-2023-037. Advance online publication. https://doi.org/10.4103/singaporemedj.SMJ-2023-037

  7. Coombes, R. C., Angelou, C., Al-Khalili, Z., Hart, W., Francescatti, D., Wright, N., Ellis, I., Green, A., Rakha, E., Shousha, S., Amrania, H., Phillips, C. C., & Palmieri, C. (2024). Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study. Breast cancer research and treatment, 10.1007/s10549-023-07229-y. Advance online publication. https://doi.org/10.1007/s10549-023-07229-y

  8. Coombes, R. C., Angelou, C., Al-Khalili, Z., Hart, W., Francescatti, D., Wright, N., Ellis, I., Green, A., Rakha, E., Shousha, S., Amrania, H., Phillips, C. C., & Palmieri, C. (2024). Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study. Breast cancer research and treatment, 10.1007/s10549-024-07276-z. Advance online publication. https://doi.org/10.1007/s10549-024-07276-z

  9. Hedskog, C., Spinner, C. D., Protzer, U., Hoffmann, D., Ko, C., Gottlieb, R. L., Askar, M., Roestenberg, M., de Vries, J. J. C., Carbo, E. C., Martin, R., Li, J., Han, D., Rodriguez, L., Parvangada, A., Perry, J. K., Ferrer, R., Antón, A., Andrés, C., Casares, V., … Porter, D. P. (2024). No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses, 16(4), 546. https://doi.org/10.3390/v16040546

  10. Huang, H. J., Schechtman, K., Askar, M., Bernadt, C., Mitter, B., Dore, P., Goodarzi, A., Yau, S., Youssef, J. G., Witt, C. A., Byers, D. E., Vazquez-Guillamet, R., Halverson, L., Nava, R., Puri, V., Kreisel, D., Gelman, A. E., & Hachem, R. R. (2024). A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation. Transplantation, 108(3), 777–786. https://doi.org/10.1097/TP.0000000000004841

  11. Ibrahim, A., Jahanifar, M., Wahab, N., Toss, M. S., Makhlouf, S., Atallah, N., Lashen, A. G., Katayama, A., Graham, S., Bilal, M., Bhalerao, A., Ahmed Raza, S. E., Snead, D., Minhas, F., Rajpoot, N., & Rakha, E. (2024). Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 37(3), 100416. https://doi.org/10.1016/j.modpat.2023.100416

  12. Ibrahim, A., Toss, M. S., Alsaleem, M., Makhlouf, S., Atallah, N., Green, A. R., & Rakha, E. A. (2024). Novel 2 Gene Signatures Associated With Breast Cancer Proliferation: Insights From Predictive Differential Gene Expression Analysis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 37(2), 100403. https://doi.org/10.1016/j.modpat.2023.100403

  13. Katayama, A., Aoki, Y., Watanabe, Y., Horiguchi, J., Rakha, E. A., & Oyama, T. (2024). Current status and prospects of artificial intelligence in breast cancer pathology: convolutional neural networks to prospective Vision Transformers. International journal of clinical oncology, 10.1007/s10147-024-02513-3. Advance online publication. https://doi.org/10.1007/s10147-024-02513-3

  14. Lashen, A., Algethami, M., Alqahtani, S., Shoqafi, A., Sheha, A., Jeyapalan, J. N., Mongan, N. P., Rakha, E. A., & Madhusudan, S. (2024). The Clinicopathological Significance of the Cyclin D1/E1-Cyclin-Dependent Kinase (CDK2/4/6)-Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers. International journal of molecular sciences, 25(7), 4060. https://doi.org/10.3390/ijms25074060

  15. Lashen, A., Al-Kawaz, A., Jeyapalan, J. N., Alqahtani, S., Shoqafi, A., Algethami, M., Toss, M., Green, A. R., Mongan, N. P., Sharma, S., Akbari, M. R., Rakha, E. A., & Madhusudan, S. (2024). Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers. Neoplasia (New York, N.Y.), 47, 100957. https://doi.org/10.1016/j.neo.2023.100957

  16. Lu, W., Lashen, A. G., Wahab, N., Miligy, I. M., Jahanifar, M., Toss, M., Graham, S., Bilal, M., Bhalerao, A., Atallah, N. M., Makhlouf, S., Ibrahim, A. Y., Snead, D., Minhas, F., Raza, S. E. A., Rakha, E., & Rajpoot, N. (2024). AI-based intra-tumor heterogeneity score of Ki67 expression as a prognostic marker for early-stage ER+/HER2- breast cancer. The journal of pathology. Clinical research, 10(1), e346. https://doi.org/10.1002/cjp2.346

  17. Makhlouf, S., Quinn, C., Toss, M., Alsaleem, M., Atallah, N. M., Ibrahim, A., Rutland, C. S., Mongan, N. P., & Rakha, E. A. (2024). Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance. European journal of cancer (Oxford, England : 1990), 197, 113473. https://doi.org/10.1016/j.ejca.2023.113473

  18. Mohamed Badie Ahmed, Khaled E Elzawawi, Ayda AlHammadi, Aysha Al-Malki, Mahir Petkar, Salim Al Lahham, Abeer Alsherawi, A malignant spiradenoma of the forehead: a case report and literature review, Oxford Medical Case Reports, Volume 2024, Issue 3, March 2024, omae016, https://doi.org/10.1093/omcr/omae016

  19. Nath, P., Alfarsi, L. H., El-Ansari, R., Masisi, B. K., Erkan, B., Fakroun, A., Ellis, I. O., Rakha, E. A., & Green, A. R. (2024). The amino acid transporter SLC7A11 expression in breast cancer. Cancer biology & therapy, 25(1), 2291855. https://doi.org/10.1080/15384047.2023.2291855

  20. Shi, Q. S., Jiang, X., Li, M., Fang, J., Fu, Z., Zhu, S., Wu, C., Meng, Q., Jie, T., & Askar, M. (2024). Microvascular activation and exocytosis after exposure to the serum from mismatched recipients by using donor microvascular cultures. Transplant immunology, 82, 101963. https://doi.org/10.1016/j.trim.2023.101963

  21. Sid Ahmed, M. A., Hamid, J. M., Hassan, A. M. M., Abu Jarir, S., Bashir Ibrahim, E., & Abdel Hadi, H. (2024). Phenotypic and Genotypic Characterization of Pan-Drug-Resistant Klebsiella pneumoniae Isolated in Qatar. Antibiotics (Basel, Switzerland), 13(3), 275. https://doi.org/10.3390/antibiotics13030275

  22. Sukik, L., Chemaitelly, H., Ayoub, H. H., Coyle, P., Tang, P., Yassine, H. M., Al Thani, A. A., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., … Abu-Raddad, L. J. (2024). Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient. Vaccine, S0264-410X(24)00440-7. Advance online publication. https://doi.org/10.1016/j.vaccine.2024.04.026

  23. Tan, P. H., Mihir, G., Laokulrath, N., & Rakha, E. (2024). Practical approach to scoring HER2 immunohistochemistry in breast cancer in the wake of updated guidelines. Histopathology, 84(4), 715–718. https://doi.org/10.1111/his.15117

  24. Wang, Y., Xu, J., Ben Abid, F., Salah, H., Sundararaju, S., Al Ismail, K., Wang, K., Sara Matthew, L., Taj-Aldeen, S., Ibrahim, E. B., Tang, P., Perez-Lopez, A., & Tsui, C. K. M. (2024). Population genomic analyses reveal high diversity, recombination and nosocomial transmission among Candida glabrata (Nakaseomyces glabrata) isolates causing invasive infections. Microbial genomics, 10(1), 001179. https://doi.org/10.1099/mgen.0.001179

  25. Weeratunga, P., Denney, L., Bull, J. A., Repapi, E., Sergeant, M., Etherington, R., Vuppussetty, C., Turner, G. D. H., Clelland, C., Woo, J., Cross, A., Issa, F., de Andrea, C. E., Melero Bermejo, I., Sims, D., McGowan, S., Zurke, Y. X., Ahern, D. J., Gamez, E. C., Whalley, J., … Ho, L. P. (2023). Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs. Nature communications, 14(1), 7216. https://doi.org/10.1038/s41467-023-42421-0

  26. Chemaitelly, H., Ayoub, H. H., Tang, P., Yassine, H. M., Al Thani, A. A., Hasan, M. R., Coyle, P., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., … Abu-Raddad, L. J. (2024). Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation. Frontiers in medicine, 11, 1363045. https://doi.org/10.3389/fmed.2024.1363045​

Hamad Medical Corporation

HMC is the principal public healthcare provider in the State of Qatar, delivering the safest, most effective and most compassionate care to each and every one of our patients.

Latest Facebook Posts

Latest Twitter Posts

Privacy Notice. © Copyright - Hamad Medical Corporation by Corporate Communications Dept.
Top